All filters
Abstracts
Evaluation of hepatitis B vaccine efficacy among healthcare worker at Laquintinie Hospital, Douala, Cameroon.
R. Kamga Wouambo
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Results of A Hepatitis C (HCV) Re-Engagement Strategy For Vulnerable Populations
G. Macphail
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Hep Free 2030: Planning for Hepatitis Elimination in Hawai`i as Nimble, Collaborative Practice
T. Pham
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Ledipasvir 90 mg/ Sofosbuvir 400 mg for treatment of Chronic Hepatitis C genotype 4 adolescents: Towards elimination of hepatitis in children
R. Soliman
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Contact tracing to engage hard to reach injection networks and achieve micro-elimination: description of the ‘source patient indentification and group overlap treatment’ (spigot) pilot program
B. Eckhardt
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Gilead Sciences’ Commitment to Global Elimination of Hepatitis C Virus
A. Son
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Global elimination of hepatitis C: meeting the World Health Organization’s 2030 goal
J. Calleja
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Short Chain Fatty Acids Delay the Pathogenesis of Hepatitis B Virus-Associated Hepatocellular Carcinoma in an HBx transgenic mouse model
M. Feitelson
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Comparative analysis of hepatitis B virus serologic profiles and biochemical markers with viral loads in Ondo, Nigeria.
M. Odimayo
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Viral hepatitis B and C seroprevalence among at risk population in Taraba state: a seroprevalence study
A. Lamiya
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Seroprevalence of viral hepatitis among health care workers (HCWS) in Taraba state, Nigeria
O. Tiwah John
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Seroprevalence of hepatitis B surface antigen (HBsAG) and hepatitis C antibodies (HCVAb) among hemodialysis patients at the Yaounde General Hospital, Cameroon.
R. Kamga Wouambo
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
High seroprevalence of viral hepatitis among animal handlers in Abeokuta, Nigeria
A. Oluremi
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Sustainability of immune response to hepatitis B virus vaccination three years after vaccination among HIV-1 infected and uninfected adults in Kenya
R. Kamoni
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Achieving sustained viral response (SVR) – is it a motivator for longterm positive lifestyle changes among people affected by VHC?
A. Schweitzer
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Co-located treatment verus co-located care coordination to engage people who inject drugs in HCV care at a syringe service program: preliminary results from the accessible care randomized clinical trial
B. Eckhardt
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Simplified HCV treatment model in primary healthcare in the country of Georgia
E. Dolmazashvili
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Depist’c pharma an innovative outreach HCV screening project in pharmacy for drugs users and general population
A. Remy
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Videos
WHO / Perspective on the Simplification Strategies - Phillippa Easterbrook, MD, FRCP, MPH, DTM&Herbroo
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Videos
Pakistan’s Model for Care - Huma Qureshi, MD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Videos
Mongolia’s Model for Care - Naranjargal Dashdorj, MD, PhD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Videos
Rwanda’s Model for Care - Jean Damascene Makuza, MD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Videos
Uganda’s Experience - Kenneth Kabagambe
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019